Breast Cancer
Researchers From Erasmus Cancer Center Validate the Clinical and Prognostic Utility of the HOXB13/IL17BR Ratio in Breast Cancer Patients
Published in Women's Health Weekly, March 15th, 2007
AviaraDx, Inc., a leader in molecular cancer diagnostics, announced the publication of an independent 1,252 patient retrospective clinical validation study in the February 20, 2007 issue of the Journal of Clinical Oncology entitled: "HOXB13- to-IL17BR expression ratio is related with tumor aggressiveness and response to tamoxifen of recurrent breast cancer" by Maurice Jansen, Anieta Sieuwerts, Jan Klijn, John Foekens, Els Berns, and colleagues at the Department of Medical Oncology, Erasmus MC/Daniel den Hoed Cancer Center, Rotterdam, The Netherlands.
Medical investigators at Erasmus Cancer Center have demonstrated that a high HOXB13-to-IL17BR ('H over I" or H/I)...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
More Articles from Women's Health Weekly
- Breastfeeding
New research explores the role of ethnicity in breastfeeding peer counseling - Heart Failure
Life-saving technology may address unique needs of women in heart failure - Incontinence
Botox 'major advance' in bringing bladder relief - Pregnancy
Risk of birth complications varies between racial groups - Sexual & Reproductive Health
Early sex may lead teens to delinquency, study shows - Alnylam Pharmaceuticals, Inc.
Alnylam Scientist Awarded Two Industry Honors - More from this issue of Women's Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
